Hydrix Ltd (ASX: HYD) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Hydrix Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $17.79 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 197.64 million
Earnings per share -0.044
Dividend per share N/A
Year To Date Return -28.00%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Hydrix Ltd (ASX: HYD)
Latest News

Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
Share Gainers

Here’s why the Hydrix (ASX: HYD) share price is shooting 70% higher

Detecting potential heart attacks early on can be a lifesaver.

Read more »

A male ASX investor wearing glasses and a beanie and denim shirt puts his hand to his chin wondering if the Wesfarmers share price is a buy
Share Market News

Hydrix (ASX:HYD) share price falling despite positive AGM update

The Hydrix share price has fallen lower today as the company held its annual general meeting for 2020. We take…

Read more »

soaring hydrix share price represented by doctor riding on top of heart high up in the clouds
Share Market News

Hydrix (ASX:HYD) share price soaring for the heavens with 54% gain

The Hydrix share price is soaring today after the company announced it has successfuly implanted its first patient in its…

Read more »

share trades
Share Market News

Hydrix and Zip were among the most traded shares on the ASX last week

Hydrix Ltd (ASX:HYD) and Zip Co Ltd (ASX:Z1P) shares were among the most traded shares on the CommSec platform last…

Read more »

Digitised heart rate and share price chart with man on ipad in background signifying share price
Share Market News

Hydrix share price rockets 250% following announcement

The Hydrix share price skyrocketed 215% by 3pm today following the company's positive AngelMed Guardian device announcement.

Read more »

a woman
⏸️ Investing

5 stocks crunched on the ASX today

The All Ordinaries manages a 0.3% gain, but these 5 stocks were crunched

Read more »

a woman
⏸️ Investing

6 stocks slammed on the ASX today

All Ordinaries ends down 0.5%, but that wasn't as bad as these stocks

Read more »

a woman
⏸️ Investing

5 ASX tech stocks set to benefit from a massive trend

As the Internet of Things gathers pace, here are 5 stocks set to benefit

Read more »

HYD ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Hydrix Ltd

Formerly Panorama Synergy Ltd (PSY), 05/11/2018

HYD Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
20 May 2022 $0.09 $0.00 0.00% 223,000 $0.09 $0.09 $0.09
19 May 2022 $0.09 $0.00 0.00% 185,712 $0.09 $0.09 $0.09
18 May 2022 $0.09 $0.00 0.00% 95,292 $0.09 $0.10 $0.09
17 May 2022 $0.09 $0.00 0.00% 1,267,270 $0.09 $0.11 $0.09
12 May 2022 $0.09 $0.00 0.00% 38,836 $0.09 $0.09 $0.09
11 May 2022 $0.09 $0.00 0.00% 92,940 $0.09 $0.09 $0.09
10 May 2022 $0.09 $0.00 0.00% 1,699,953 $0.09 $0.09 $0.07
09 May 2022 $0.09 $0.00 0.00% 1,062 $0.10 $0.10 $0.09
06 May 2022 $0.10 $0.00 0.00% 140,224 $0.10 $0.10 $0.10
05 May 2022 $0.10 $0.00 0.00% 39,243 $0.10 $0.10 $0.10
04 May 2022 $0.10 $-0.01 -9.52% 333,268 $0.10 $0.10 $0.10
03 May 2022 $0.11 $0.00 0.00% 115,947 $0.11 $0.11 $0.11
02 May 2022 $0.11 $0.00 0.00% 1,000 $0.11 $0.11 $0.11
29 Apr 2022 $0.11 $0.00 0.00% 71,122 $0.11 $0.11 $0.11
28 Apr 2022 $0.11 $0.01 10.20% 250,288 $0.11 $0.11 $0.11
27 Apr 2022 $0.10 $0.00 0.00% 1,572 $0.10 $0.10 $0.10
26 Apr 2022 $0.10 $0.00 0.00% 254,925 $0.11 $0.11 $0.10
22 Apr 2022 $0.10 $0.00 0.00% 273,711 $0.11 $0.11 $0.10

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
14 Apr 2022 Paul Lewis Issued 2 $198,000
Placement.
14 Apr 2022 Paul Lewis Issued 2 $200,000
Placement.
14 Apr 2022 Paul Wright Issued 250 $24,750
Placement.
14 Apr 2022 Paul Wright Issued 250 $25,000
Placement.
14 Apr 2022 Joanne Bryant Issued 250 $25,000
Placement.
14 Apr 2022 Joanne Bryant Issued 250 $24,750
Placement.
14 Apr 2022 Gavin Coote Issued 1 $100,000
Placement.
14 Apr 2022 Gavin Coote Issued 1 $99,000
Placement.
14 Apr 2022 Julie King Issued 2 $247,500
Placement.
14 Apr 2022 Julie King Issued 2 $250,000
Placement.
13 Jan 2022 Gavin Coote Issued 5 $682,500
Issue of securities. 5,500,000 Performance Rights
29 Nov 2021 Paul Wright Exercise 150 $18,750
Conversion of securities.
29 Nov 2021 Paul Wright Issued 150 $18,750
Conversion of securities.
26 Nov 2021 Gavin Coote Cancelled 31 $4,062
Cancellation of securities. 250,000 - Performance Rights
31,250 Performance Rights were forfeited
26 Nov 2021 Gavin Coote Issued 468 $60,937
Conversion of securities.
26 Nov 2021 Gavin Coote Exercise 468 $60,937
Conversion of securities.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Paul Anthony Lewis Non-Executive Director Oct 2021
Mr started his career in technology leadership positions with companies including Mobil Oil Corporation and ICL across the UK, Europe and Australia, Mr Lewis became Managing Partner for PA Consulting - Asia, where he established and led offices in Hong Kong, Japan, Malaysia, and Singapore for 12 years. Since retiring from global executive life, Mr Lewis has spent the past 15+ years specialising in a variety of Non-Executive Director and Advisory roles. Current directorships held by Mr Lewis include Volt Bank Limited, Grassrootz, the Australian British Chamber of Commerce and Chair of ipSCAPE. Mr Lewis recently retired from the Board of the Magellan Financial Group after 15 years where he had served as Director from its inception. He was also Chair of Optal. He has served on several advisory boards such as the Hong Kong Inward Investment Advisory Board, Infrastructure Forum in Indonesia, the British Telecom Global Advisory Board and as Chair of NAB Private Advisory Board. Mr Lewis held Board roles with Cure Cancer and Tobacco Free and is currently the Chair of the GWS Giants Foundation.
Mr Paul Wright Non-Executive Director Aug 2018
Mr Wright has spent 18 years as CEO of three of Australia's international technology companies. At ASX-listed Universal Biosensors ("UBI"), Paul built long term partnerships with global diagnostics leaders Siemens Healthcare and Johnson & Johnson. Before UBI, Paul was CEO of Invetech (1999-2007) and Vision BioSystems (2007-2008), the major subsidiary of ASX-listed Vision Systems Limited that developed, manufactured and marketed diagnostic instruments and consumables to pathology laboratories worldwide. Prior to this, Paul spent over 8 years working in Europe, North America and Asia with corporate strategy consultants Bain & Company, advising multi-national clients on growth strategy, mergers and acquisitions, and manufacturing improvement.
Ms Joanne Bryant Non-Executive Director Nov 2016
Ms Bryant brings more than 40 years of experience in the health sciences as an occupational therapist, trainer and vocational specialist. She has worked for many years as an approved Rehabilitation Provider, providing injury management services to both Commonwealth and State organisations. She also manages a small privately owned investment company.
Mr Gavin Coote Executive ChairmanExecutive Director Jan 2017
Mr Coote brings 25+ years executive leadership in corporate and financial strategy, and private equity experience. His experience includes 5 years with PricewaterhouseCoopers in Australia and the USA, a decade in technology mergers & acquisitions, corporate development, and venture investing in the United States, and fifteen years in Australian private equity in various sectors healthcare, industrial and residential construction materials, leisure and hospitality, and sports and entertainment.
Ms Julie King Non-Executive Director Mar 2017
Ms King has 40 years of experience in various industries including utilities, maritime, airline, banking and FMCG, she has experience in commercial negotiations and performance leadership and culture programs.
Ms Alyn Tai Company Secretary Jun 2016
-
Alyn Tai Company Secretary
-
Peter R Lewis Executive Vice President Corporate Development
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
John W King Nominees Pty Ltd 17,639,345 10.74%
National Nominees Limited 9,790,737 5.96%
Patagorang Pty Limited <Roger Allen Family A/C> 6,666,666 4.06%
Invia Custodian Pty Limited <Paj Lewis Super Fund A/C> 3,958,333 2.41%
Invia Custodian Pty Limited <The Paj A/C> 3,958,333 2.41%
Jasper Capital Ltd 3,000,000 1.83%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 2,075,264 1.26%
Mr Peter David Russell & Ms Dominique Karen Du Maurier 2,000,000 1.22%
Goetzke Super Company Pty Ltd <H & P Goetzke S/F A/C> 1,989,494 1.21%
Beachridge Advisory Services Pty Ltd <The Coote Family Discr A/C> 1,970,385 1.20%
Patagorang Pty Ltd 1,785,714 1.09%
Sandhurst Trustees Ltd <Jmfg Consol A/C> 1,555,975 0.95%
Australian Philanthropic & Services Foundation P/L <Australian Phil 1,525,000 0.93%
Lampsac Pty Ltd <Central Coast Superfund A/C> 1,367,952 0.83%
BNP Paribas Noms Pty Ltd <Drp> 1,352,529 0.82%
Flet Superannuation Pty Ltd <Walsh Superannuation A/C> 1,207,030 0.73%
Bridgestar Pty Ltd 1,200,000 0.73%
HSBC Custody Nominees (Australia) Limited 1,139,989 0.69%
Citicorp Nominees Pty Limited 1,139,653 0.69%
Memphasys Limited 1,000,000 0.61%

Profile

since

Note